as on January 28, 2026 at 9:42 pm IST
Day's Low
Day's High
0.43%
Downside
5.03%
Upside
52 Week's Low
52 Week's High
49.06%
Downside
26.20%
Upside
Check Moderna, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.8B
EPS (TTM)
-7.951
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.85%
PE Ratio (TTM)
-5.08
Industry PE ratio
22.894109589041097
PEG Ratio
0EBITDA
-3.3B
Revenue (TTM)
2.2B
Profit Margin
-139.61%
Return On Equity TTM
-29.32%
Track how Moderna, Inc. P/E has moved over time to understand its valuation trends.
Moderna, Inc. in the last 5 years
Lowest (-15.78x)
September 30, 2024
Today (-5.08x)
January 28, 2026
Industry (22.89x)
January 28, 2026
Highest (115.93x)
March 31, 2021
Today’s Price to Earnings Ratio: -5.08x
Compare market cap, revenue, PE, and other key metrics of Moderna, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $18.8B | -71.51% | -5.08 | -139.61% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Moderna, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moderna, Inc. investment value today
Current value as on today
₹1,03,304
Returns
₹3,304
(+3.3%)
Returns from Moderna, Inc. Stock
Dollar Returns*
₹5,974 (+5.97%)
Based on 31 analysts
54.84%
Buy
35.48%
Hold
9.68%
Sell
Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna, Inc.. Average target price of $37.7
Get share price movements and forecasts by analysts on Moderna, Inc..
What analysts predicted
-16.02%DOWNSIDE
Target Price
$37.7
Current Price
$43.74
Analyzed by
31 Analysts
Target
$37.70
Moderna, Inc. target price $37.7, a slight downside of -16.02% compared to current price of $43.74. According to 31 analysts rating.
Investment in Moderna, Inc. Shares on INDmoney has grown by 86.88% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:86.88% versus previous 30 day period
Search interest for Moderna, Inc. Stock has increased by 89% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:89% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 22 January
Thu, 09:21 PM
-Moderna stock hits a new 52-week high after positive cancer trial results, showing a 49% reduction in recurrence risk.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 107.0M → 1.01B (in $), with an average increase of 55.3% per quarter
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -1.12B → -200.0M (in $), with an average increase of 115.2% per quarter
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 47.2%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 105.4%
Price Dip
![]()
In the last 7 days, MRNA stock has moved down by -8.8%
| Organisation | Moderna, Inc. |
| Headquarters | 325 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Stéphane Bancel |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Dave Johnson | Chief Data & AI Officer |
Dr. Charbel Haber M.P.H., Ph.D. | Senior VP & Head of Global Regulatory Science |
Mr. Stéphane Bancel | CEO & Director |
Dr. Stephen Hoge M.D. | President |
Dr. Melanie Ivarsson M.B.A., O.B.E., Ph.D. | Chief Development Officer |
Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations |
Ms. Tracey Franklin | Chief People & Digital Technology Officer |
Mr. James M. Mock | Chief Financial Officer |
Ms. Shannon Thyme Klinger J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer |
Moderna, Inc. share price today is $43.74 as on . Moderna, Inc. share today touched a day high of $45.94 and a low of $43.55.
Moderna, Inc. share touched a 52 week high of $55.2 on and a 52 week low of $22.28 on . Moderna, Inc. stock price today i.e. is trending at $43.74,which is 20.76% down from its 52 week high and 96.32% up from its 52 week low.
Moderna, Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Moderna, Inc. (MRNA) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Moderna, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moderna, Inc. share’s latest price of $43.74 as on January 28, 2026 at 9:42 pm IST, you will get 0.2286 shares of Moderna, Inc.. Learn more about
fractional shares .
Moderna, Inc. stock has given -71.51% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?